Symbols / NOTV
NOTV Chart
About
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 9.12M |
| Enterprise Value | 472.36M | Income | -69.37M | Sales | 514.03M |
| Book/sh | 3.17 | Cash/sh | 0.37 | Dividend Yield | — |
| Payout | 0.00% | Employees | 1945 | IPO | — |
| P/E | — | Forward P/E | -5.30 | PEG | — |
| P/S | 0.02 | P/B | 0.08 | P/C | — |
| EV/EBITDA | 26.71 | EV/Sales | 0.92 | Quick Ratio | 0.17 |
| Current Ratio | 0.30 | Debt/Eq | 436.57 | LT Debt/Eq | — |
| EPS (ttm) | -1.92 | EPS next Y | -0.05 | EPS Growth | — |
| Revenue Growth | 0.80% | Earnings | 2026-05-06 | ROA | -3.14% |
| ROE | -49.76% | ROIC | — | Gross Margin | 23.49% |
| Oper. Margin | -13.36% | Profit Margin | -13.50% | Shs Outstand | 34.40M |
| Shs Float | 31.79M | Short Float | 6.35% | Short Ratio | 6.52 |
| Short Interest | — | 52W High | 4.29 | 52W Low | 0.25 |
| Beta | 4.16 | Avg Volume | 463.94K | Volume | 295.11K |
| Target Price | $3.25 | Recom | None | Prev Close | $0.28 |
| Price | $0.27 | Change | -4.64% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$3.25
Mean price target
2. Current target
$0.27
Latest analyst target
3. DCF / Fair value
$-1.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.27
Low
$1.50
High
$5.00
Mean
$3.25
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-10 | main | Lake Street | Buy → Buy | $2 |
| 2025-12-04 | main | Lake Street | Buy → Buy | $3 |
| 2025-05-08 | main | Lake Street | Buy → Buy | $5 |
| 2024-09-30 | up | Lake Street | Hold → Buy | $4 |
| 2024-05-16 | down | Lake Street | Buy → Hold | $2 |
| 2024-05-16 | main | Craig-Hallum | Buy → Buy | $10 |
| 2024-05-14 | down | Jefferies | Buy → Hold | $4 |
| 2024-02-09 | up | Jefferies | Hold → Buy | $12 |
| 2023-12-12 | main | Craig-Hallum | Buy → Buy | $25 |
| 2023-07-20 | init | Wells Fargo | — → Overweight | $9 |
| 2023-01-19 | down | Jefferies | Buy → Hold | $8 |
| 2023-01-11 | up | Lake Street | Hold → Buy | $10 |
| 2022-11-18 | down | Lake Street | Buy → Hold | $7 |
| 2022-10-04 | init | Jefferies | — → Buy | $27 |
| 2022-08-11 | main | Lake Street | — → Buy | $60 |
| 2022-01-31 | init | Lake Street | — → Buy | $60 |
| 2021-09-20 | init | Craig-Hallum | — → Buy | $45 |
- Drug research firm Inotiv reports unauthorized access to personal data - Stock Titan Fri, 13 Feb 2026 21
- $NOTV ($NOTV) Releases Q1 2026 Earnings - Quiver Quantitative Mon, 09 Feb 2026 08
- Inotiv Inc. (NASDAQ:NOTV) Reports Q1 Revenue Miss and Widened Loss, Shares Drop - ChartMill Mon, 09 Feb 2026 13
- Inotiv Reveals Preliminary Q4 And FY2025 Revenue, Stock Jumps - Nasdaq ue, 18 Nov 2025 08
- Positive Sentiment Still Eludes Inotiv, Inc. (NASDAQ:NOTV) Following 28% Share Price Slump - simplywall.st Fri, 27 Jun 2025 07
- Inotiv beats Q4 estimates, but shares flat on debt refinancing concerns - Investing.com Wed, 03 Dec 2025 08
- Top Exec Quietly Dumps Inotiv Shares - TipRanks ue, 03 Feb 2026 08
- Inotiv (NASDAQ: NOTV) guides fourth-quarter revenue near $138M and full-year around $513M - Stock Titan Mon, 17 Nov 2025 08
- Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga ue, 18 Nov 2025 08
- $NOTV stock is up 11% today. Here's what we see in our data. - Quiver Quantitative ue, 18 Nov 2025 08
- NOTV, APLT Lead After-Hours Biotech Gains; ALMS, TELA, CORT, BRTX Also Advance - Nasdaq Mon, 17 Nov 2025 08
- Earnings call transcript: Inotiv reports Q4 2025 earnings beat, stock surges - Investing.com Wed, 03 Dec 2025 08
- Inotiv Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line - simplywall.st Sat, 09 Aug 2025 07
- Human liver cell platform aims to make future medicines safer, faster - Stock Titan ue, 13 Jan 2026 08
- $NOTV ($NOTV) Q4 2025 Earnings Results - Quiver Quantitative Wed, 03 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2119 | 616 | — | Sale at price 0.29 per share. | SAGARTZ JOHN E | Officer | — | 2026-02-17 00:00:00 | D |
| 1 | 16810 | 4964 | — | Sale at price 0.30 per share. | LEASURE ROBERT JR. | Chief Executive Officer | — | 2026-02-17 00:00:00 | D |
| 2 | 2888 | 846 | — | Sale at price 0.29 per share. | TAYLOR BETH A | Chief Financial Officer | — | 2026-02-17 00:00:00 | D |
| 3 | 113297 | 57034 | — | Sale at price 0.50 per share. | LEASURE ROBERT JR. | Chief Executive Officer | — | 2026-02-02 00:00:00 | D |
| 4 | 2000 | 1771 | — | Sale at price 0.89 per share. | NEFF R MATTHEW | Director | — | 2025-12-01 00:00:00 | D |
| 5 | 2000 | 2487 | — | Sale at price 1.24 per share. | NEFF R MATTHEW | Director | — | 2025-11-03 00:00:00 | D |
| 6 | 10000 | 19400 | — | Conversion of Exercise of derivative security at price 1.94 per share. | NEFF R MATTHEW | Director | — | 2025-10-24 00:00:00 | D |
| 7 | 2000 | 2858 | — | Sale at price 1.43 per share. | NEFF R MATTHEW | Director | — | 2025-10-01 00:00:00 | D |
| 8 | 2000 | 3338 | — | Sale at price 1.67 per share. | NEFF R MATTHEW | Director | — | 2025-09-02 00:00:00 | D |
| 9 | 2000 | 3818 | — | Sale at price 1.91 per share. | NEFF R MATTHEW | Director | — | 2025-08-01 00:00:00 | D |
Financials
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 1.33M | -5.33M | -11.27M | -12.20M |
| TaxRateForCalcs | 0.22 | 0.17 | 0.16 | 0.04 |
| NormalizedEBITDA | 18.66M | 5.19M | 45.71M | 10.28M |
| TotalUnusualItems | 6.10M | -31.94M | -72.22M | -283.70M |
| TotalUnusualItemsExcludingGoodwill | 6.10M | -31.94M | -72.22M | -283.70M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -68.62M | -108.44M | -105.14M | -337.02M |
| ReconciledDepreciation | 55.93M | 57.12M | 54.72M | 49.32M |
| ReconciledCostOfRevenue | 392.04M | 379.57M | 390.48M | 372.01M |
| EBITDA | 24.75M | -26.76M | -26.51M | -273.42M |
| EBIT | -31.18M | -83.88M | -81.22M | -322.75M |
| NetInterestIncome | -56.59M | -46.88M | -43.02M | -29.70M |
| InterestExpense | 56.59M | 46.88M | 43.02M | 29.70M |
| NormalizedIncome | -73.39M | -81.84M | -44.19M | -65.51M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -68.62M | -108.44M | -105.14M | -337.02M |
| TotalExpenses | 550.02M | 545.20M | 581.66M | 527.40M |
| TotalOperatingIncomeAsReported | -30.90M | -86.41M | -81.46M | -263.45M |
| DilutedAverageShares | 32.45M | 25.90M | 25.64M | 24.35M |
| BasicAverageShares | 32.45M | 25.90M | 25.64M | 24.35M |
| DilutedEPS | -2.11 | -4.19 | -4.10 | -13.84 |
| BasicEPS | -2.11 | -4.19 | -4.10 | -13.84 |
| DilutedNIAvailtoComStockholders | -68.62M | -108.44M | -105.14M | -337.02M |
| AverageDilutionEarnings | -8.32M | |||
| NetIncomeCommonStockholders | -68.62M | -108.44M | -105.14M | -337.02M |
| NetIncome | -68.62M | -108.44M | -105.14M | -337.02M |
| MinorityInterests | 0.00 | 440.00K | -238.00K | 244.00K |
| NetIncomeIncludingNoncontrollingInterests | -68.62M | -108.89M | -104.90M | -337.26M |
| NetIncomeContinuousOperations | -68.62M | -108.89M | -104.90M | -337.26M |
| TaxProvision | -19.14M | -21.88M | -19.34M | -15.19M |
| PretaxIncome | -87.77M | -130.76M | -124.24M | -352.45M |
| OtherIncomeExpense | 5.82M | -29.41M | -71.98M | -343.00M |
| OtherNonOperatingIncomeExpenses | -273.00K | 2.53M | 237.00K | -59.29M |
| SpecialIncomeCharges | 6.10M | -31.94M | -72.22M | -283.70M |
| OtherSpecialCharges | -7.55M | 28.50M | ||
| ImpairmentOfCapitalAssets | 0.00 | 0.00 | 66.37M | 236.00M |
| RestructuringAndMergernAcquisition | 1.45M | 3.44M | 5.85M | 47.70M |
| GainOnSaleOfSecurity | 762.00K | |||
| NetNonOperatingInterestIncomeExpense | -56.59M | -46.88M | -43.02M | -29.70M |
| InterestExpenseNonOperating | 56.59M | 46.88M | 43.02M | 29.70M |
| OperatingIncome | -37.00M | -54.46M | -9.24M | 20.25M |
| OperatingExpense | 157.98M | 165.63M | 191.18M | 136.96M |
| OtherOperatingExpenses | 9.81M | 10.60M | 12.68M | 6.99M |
| DepreciationAmortizationDepletionIncomeStatement | 55.93M | 57.12M | 54.72M | 30.89M |
| DepreciationAndAmortizationInIncomeStatement | 55.93M | 57.12M | 54.72M | 30.89M |
| Amortization | 55.93M | 57.12M | 54.72M | 30.89M |
| AmortizationOfIntangiblesIncomeStatement | 55.93M | 57.12M | 54.72M | 30.89M |
| ResearchAndDevelopment | 405.00K | |||
| SellingGeneralAndAdministration | 92.24M | 97.92M | 123.78M | 99.09M |
| SellingAndMarketingExpense | 21.14M | 20.88M | 19.07M | 16.65M |
| GeneralAndAdministrativeExpense | 71.10M | 77.03M | 104.71M | 82.44M |
| OtherGandA | 71.10M | 77.03M | 104.71M | 82.44M |
| GrossProfit | 120.98M | 111.17M | 181.94M | 157.21M |
| CostOfRevenue | 392.04M | 379.57M | 390.48M | 390.44M |
| TotalRevenue | 513.02M | 490.74M | 572.42M | 547.66M |
| OperatingRevenue | 513.02M | 490.74M | 572.42M | 547.66M |
| Line Item | 2023-09-30 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 34.36M | 26.02M | 25.78M | 25.60M |
| ShareIssued | 34.36M | 26.02M | 25.78M | 25.60M |
| NetDebt | 383.38M | 371.91M | 342.25M | 335.14M |
| TotalDebt | 459.29M | 445.77M | 417.64M | 386.49M |
| TangibleBookValue | -198.46M | -198.18M | -133.56M | -143.34M |
| InvestedCapital | 541.15M | 563.84M | 646.90M | 714.03M |
| WorkingCapital | -362.19M | 44.37M | 81.61M | 68.88M |
| NetTangibleAssets | -198.46M | -198.18M | -133.56M | -143.34M |
| CapitalLeaseObligations | 54.16M | 52.43M | 39.90M | 32.84M |
| CommonStockEquity | 136.03M | 170.50M | 269.15M | 360.37M |
| TotalCapitalization | 136.03M | 560.30M | 638.95M | 691.05M |
| TotalEquityGrossMinorityInterest | 136.03M | 170.50M | 268.49M | 359.77M |
| MinorityInterest | 0.00 | -664.00K | -606.00K | 0.00 |
| StockholdersEquity | 136.03M | 170.50M | 269.15M | 360.37M |
| GainsLossesNotAffectingRetainedEarnings | 2.23M | 1.41M | 330.00K | -5.50M |
| OtherEquityAdjustments | 2.23M | 1.41M | 330.00K | -5.50M |
| RetainedEarnings | -630.81M | -562.16M | -453.28M | -348.28M |
| AdditionalPaidInCapital | 756.06M | 724.79M | 715.70M | 707.79M |
| CapitalStock | 8.55M | 6.47M | 6.41M | 6.36M |
| CommonStock | 8.55M | 6.47M | 6.41M | 6.36M |
| PreferredStock | 0.00 | |||
| TotalLiabilitiesNetMinorityInterest | 635.09M | 610.86M | 588.04M | 603.13M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 78.30M | 491.81M | 455.85M | 439.04M |
| OtherNonCurrentLiabilities | 13.29M | 17.56M | 6.37M | 6.48M |
| NonCurrentDeferredLiabilities | 18.24M | 44.01M | 50.06M | 77.03M |
| NonCurrentDeferredRevenue | 12.66M | 16.97M | ||
| NonCurrentDeferredTaxesLiabilities | 5.57M | 27.04M | 50.06M | 77.03M |
| LongTermDebtAndCapitalLeaseObligation | 46.77M | 430.24M | 399.41M | 355.53M |
| LongTermCapitalLeaseObligation | 46.77M | 40.44M | 29.61M | 24.85M |
| LongTermDebt | 389.80M | 369.80M | 330.68M | 154.21M |
| CurrentLiabilities | 556.78M | 119.04M | 132.19M | 164.10M |
| OtherCurrentLiabilities | 7.52M | 4.73M | 5.24M | 11.91M |
| CurrentDeferredLiabilities | 51.51M | 41.99M | 55.62M | 68.64M |
| CurrentDeferredRevenue | 51.51M | 41.99M | 55.62M | 68.64M |
| CurrentDebtAndCapitalLeaseObligation | 412.51M | 15.52M | 18.23M | 30.96M |
| CurrentCapitalLeaseObligation | 7.39M | 11.98M | 10.28M | 7.98M |
| CurrentDebt | 405.12M | 3.54M | 7.95M | 22.98M |
| OtherCurrentBorrowings | 402.12M | 3.54M | 7.95M | 7.98M |
| LineOfCredit | 3.00M | 0.00 | 0.00 | 15.00M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 12.83M | 10.85M | 12.97M | 17.46M |
| PayablesAndAccruedExpenses | 72.41M | 45.95M | 40.13M | 35.12M |
| CurrentAccruedExpenses | 20.39M | 8.02M | 2.98M | 5.23M |
| InterestPayable | 4.39M | 3.02M | 2.98M | 5.23M |
| Payables | 52.02M | 37.94M | 37.16M | 29.89M |
| OtherPayable | 4.89M | |||
| TotalTaxPayable | 3.49M | 4.41M | 4.60M | 1.20M |
| AccountsPayable | 48.53M | 33.53M | 32.56M | 28.70M |
| TotalAssets | 771.11M | 781.36M | 856.53M | 962.90M |
| TotalNonCurrentAssets | 576.52M | 617.95M | 642.73M | 729.92M |
| OtherNonCurrentAssets | 1.65M | 1.90M | 3.36M | 3.06M |
| DefinedPensionBenefit | 2.77M | 3.14M | 3.04M | 1.57M |
| NonCurrentPrepaidAssets | 6.08M | 3.68M | 2.89M | 0.00 |
| NonCurrentNoteReceivables | 7.64M | 6.08M | ||
| GoodwillAndOtherIntangibleAssets | 334.48M | 368.68M | 402.71M | 503.71M |
| OtherIntangibleAssets | 240.20M | 274.40M | 308.43M | 345.89M |
| Goodwill | 94.29M | 94.29M | 94.29M | 157.82M |
| NetPPE | 229.98M | 238.15M | 229.93M | 218.69M |
| AccumulatedDepreciation | -114.06M | -94.19M | -74.64M | -55.45M |
| GrossPPE | 344.04M | 332.34M | 304.57M | 274.14M |
| ConstructionInProgress | 16.78M | 9.49M | 25.80M | 40.52M |
| OtherProperties | 52.56M | 53.17M | 42.53M | 32.49M |
| MachineryFurnitureEquipment | 104.64M | 98.42M | 84.59M | 70.53M |
| BuildingsAndImprovements | 142.15M | 140.49M | 120.93M | 110.57M |
| LandAndImprovements | 27.91M | 30.77M | 30.71M | 20.02M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 194.59M | 163.41M | 213.80M | 232.98M |
| OtherCurrentAssets | 6.77M | 4.86M | 6.82M | 8.25M |
| AssetsHeldForSaleCurrent | 0.00 | 1.42M | 0.00 | |
| RestrictedCash | 0.00 | 465.00K | 18.00M | |
| PrepaidAssets | 22.90M | 41.51M | 23.55M | 33.87M |
| Inventory | 45.74M | 18.17M | 56.10M | 71.44M |
| InventoriesAdjustmentsAllowances | -2.62M | -2.80M | -3.24M | -3.49M |
| OtherInventories | 41.67M | 14.87M | 52.52M | 68.06M |
| FinishedGoods | 5.03M | 4.17M | 4.44M | 4.93M |
| WorkInProcess | 0.00 | 61.00K | 124.00K | 186.00K |
| RawMaterials | 1.65M | 1.87M | 2.26M | 1.76M |
| Receivables | 97.45M | 77.44M | 90.42M | 100.44M |
| ReceivablesAdjustmentsAllowances | -6.40M | -6.93M | -7.45M | -6.27M |
| OtherReceivables | 27.42M | 14.62M | 17.21M | 17.47M |
| TaxesReceivable | 2.26M | 2.60M | 1.81M | 366.00K |
| NotesReceivable | 0.00 | 1.28M | 1.23M | 0.00 |
| AccountsReceivable | 74.16M | 65.87M | 77.62M | 88.87M |
| AllowanceForDoubtfulAccountsReceivable | -668.00K | |||
| GrossAccountsReceivable | 21.40M | |||
| CashCashEquivalentsAndShortTermInvestments | 21.74M | 21.43M | 35.49M | 18.52M |
| CashAndCashEquivalents | 21.74M | 21.43M | 35.49M | 18.52M |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| FreeCashFlow | -27.07M | -29.11M | 380.00K | -41.52M |
| RepaymentOfDebt | -27.95M | -15.45M | -23.07M | -59.74M |
| IssuanceOfDebt | 26.00M | 29.00M | 41.00M | 274.00M |
| IssuanceOfCapitalStock | 27.52M | 0.00 | 0.00 | 0.00 |
| CapitalExpenditure | -16.61M | -22.31M | -27.50M | -36.30M |
| InterestPaidSupplementalData | 38.84M | 36.14M | 35.46M | 17.06M |
| IncomeTaxPaidSupplementalData | 749.00K | 1.84M | 7.15M | 479.00K |
| EndCashPosition | 21.74M | 21.43M | 35.49M | 18.98M |
| BeginningCashPosition | 21.43M | 35.49M | 18.98M | 156.92M |
| EffectOfExchangeRateChanges | -46.00K | -98.00K | 1.51M | -2.16M |
| ChangesInCash | 355.00K | -13.96M | 15.00M | -135.79M |
| FinancingCashFlow | 23.70M | 9.68M | 15.87M | 203.15M |
| CashFlowFromContinuingFinancingActivities | 23.70M | 9.68M | 15.87M | 203.15M |
| NetOtherFinancingCharges | -1.88M | -3.87M | -2.06M | -11.22M |
| ProceedsFromStockOptionExercised | 110.00K | 118.00K | 246.00K | |
| NetCommonStockIssuance | 27.52M | 0.00 | 0.00 | 0.00 |
| CommonStockIssuance | 27.52M | 0.00 | 0.00 | 0.00 |
| NetIssuancePaymentsOfDebt | -1.95M | 13.55M | 17.93M | 214.26M |
| NetShortTermDebtIssuance | -15.00M | 15.00M | 2.14M | |
| ShortTermDebtPayments | -21.00M | -19.00M | 0.00 | |
| ShortTermDebtIssuance | 6.00M | 34.00M | 2.14M | |
| NetLongTermDebtIssuance | -1.95M | 13.55M | 17.93M | 199.26M |
| LongTermDebtPayments | -27.95M | -15.45M | -23.07M | -40.74M |
| LongTermDebtIssuance | 26.00M | 29.00M | 41.00M | 240.00M |
| InvestingCashFlow | -12.89M | -16.83M | -28.75M | -333.72M |
| CashFlowFromContinuingInvestingActivities | -12.89M | -16.83M | -28.75M | -333.72M |
| NetOtherInvestingChanges | -2.37M | |||
| NetBusinessPurchaseAndSale | 0.00 | -297.71M | -41.59M | |
| PurchaseOfBusiness | 0.00 | -297.71M | -41.59M | |
| NetPPEPurchaseAndSale | 3.72M | 5.48M | 1.11M | 290.00K |
| SaleOfPPE | 3.72M | 5.48M | 1.11M | 290.00K |
| CapitalExpenditureReported | -16.61M | -22.31M | -27.50M | -36.30M |
| OperatingCashFlow | -10.46M | -6.80M | 27.88M | -5.22M |
| CashFlowFromContinuingOperatingActivities | -10.46M | -6.80M | 27.88M | -5.22M |
| ChangeInWorkingCapital | -1.14M | 52.60M | 16.96M | -40.28M |
| ChangeInOtherWorkingCapital | 1.38M | 13.81M | -15.48M | 32.19M |
| ChangeInPayablesAndAccruedExpense | 26.39M | 2.77M | -2.38M | 6.62M |
| ChangeInAccruedExpense | 14.05M | 2.16M | -8.34M | 14.66M |
| ChangeInPayable | 12.34M | 613.00K | 5.96M | -8.04M |
| ChangeInAccountPayable | 12.34M | 613.00K | 5.96M | -8.04M |
| ChangeInTaxPayable | 0.00 | |||
| ChangeInIncomeTaxPayable | 0.00 | |||
| ChangeInPrepaidAssets | 2.50M | -16.36M | 11.25M | -20.05M |
| ChangeInInventory | -27.59M | 38.21M | 14.01M | -35.20M |
| ChangeInReceivables | -3.83M | 14.17M | 9.55M | -23.84M |
| ChangesInAccountReceivables | -3.83M | 14.17M | 9.55M | -23.84M |
| OtherNonCashItems | 19.46M | 10.67M | 11.44M | 22.61M |
| StockBasedCompensation | 6.03M | 6.74M | 7.84M | 24.20M |
| ProvisionandWriteOffofAssets | -492.00K | 58.00K | 1.27M | 1.31M |
| AssetImpairmentCharge | 0.00 | 0.00 | 66.37M | 236.00M |
| DeferredTax | -21.61M | -23.25M | -25.81M | -17.84M |
| DeferredIncomeTax | -21.61M | -23.25M | -25.81M | -17.84M |
| DepreciationAmortizationDepletion | 55.93M | 57.12M | 54.72M | 49.32M |
| DepreciationAndAmortization | 55.93M | 57.12M | 54.72M | 49.32M |
| Depreciation | 6.27M | |||
| OperatingGainsLosses | -1.86M | 56.71M | -13.21M | |
| GainLossOnInvestmentSecurities | 56.71M | -8.36M | ||
| NetIncomeFromContinuingOperations | -68.62M | -108.89M | -104.90M | -337.26M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NOTV
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|